LONDON, ON, Nov. 12, 2018 /CNW/ - The Avandia drug class action lawsuit has reached a Canada-wide settlement, Siskinds LLP announced today.
The settlement applies to Canadians who were prescribed the drug Avandia before November 15, 2018 and, if that person is deceased, to their spouse, children, grandchildren, parents, grandparents and siblings (together "Class Members").
Compensation may be available to Class Members who suffered a heart attack, congestive heart failure, coronary artery bypass graft (CABG), and/ or coronary intervention stent placement.
Class Members who do not wish to participate in the lawsuit must opt out by January 15, 2019. Resources are available to Class Members on the official case website, www.avandiaclassaction.ca.
SOURCE Siskinds LLP
Advertisement
The settlement applies to Canadians who were prescribed the drug Avandia before November 15, 2018 and, if that person is deceased, to their spouse, children, grandchildren, parents, grandparents and siblings (together "Class Members").
Advertisement
Compensation may be available to Class Members who suffered a heart attack, congestive heart failure, coronary artery bypass graft (CABG), and/ or coronary intervention stent placement.
Class Members who do not wish to participate in the lawsuit must opt out by January 15, 2019. Resources are available to Class Members on the official case website, www.avandiaclassaction.ca.
SOURCE Siskinds LLP
